Japan's Taisho ends year with sales down 2.1%

17 May 2019 - Deborah Wilkes

Premium

Japan's Taisho Pharmaceutical reported Self-Medication sales down by 2.1% in the 12 months ended 31 March 2019, as it prepares to acquire Bristol-Myers Squibb's French consumer healthcare business UPSA.

Click tags below for more information on topics:

Taisho

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: